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Abstract
Background: Whether early detection and treatment of prostate cancer (PCa) will reduce disease-related mortality
remains uncertain. As a result, tools are needed to facilitate informed decision making. While there have been several
decision aids (DAs) developed and tested, very few have included an exercise to help men clarify their values and
preferences about PCa screening. Further, only one DA has utilized an interactive web-based format, which allows for
an expansion and customization of the material. We describe the development of two DAs, a booklet and an
interactive website, each with a values clarification component and designed for use in diverse settings.
Methods: We conducted two feasibility studies to assess men’s (45-70 years) Internet access and their willingness
to use a web- vs. a print-based tool. The booklet was adapted from two previous versions evaluated in randomized
controlled trials (RCTs) and the website was created to closely match the content of the revised booklet. Usability
testing was conducted to obtain feedback regarding draft versions of the materials. The tools were also reviewed
by a plain language expert and the interdisciplinary research team. Feedback on the content and presentation led
to iterative modifications of the tools.
Results: The feasibility studies confirmed that the Internet was a viable medium, as the majority of men used a
computer, had access to the Internet, and Internet use increased over time. Feedback from the usability testing on
the length, presentation, and content of the materials was incorporated into the final versions of the booklet and
website. Both the feasibility studies and the usability testing highlighted the need to address men’s informed
decision making regarding screening.
Conclusions: Informed decision making for PCa screening is crucial at present and may be important for some
time, particularly if a definitive recommendation either for or against screening does not emerge from ongoing
prostate cancer screening trials. We have detailed our efforts at developing print- and web-based DAs to assist
men in determining how to best meet their PCa screening preferences. Following completion of our ongoing RCT
designed to test these materials, our goal will be to develop a dissemination project for the more effective tool.
Trial Registration: NCT00623090
Background
Prostate cancer (PCa) is the leading cancer diagnosis
among men and the second leading cause of male can-
cer death [1,2]. While research has shown that PCa
screening can find cancer at its earliest stages, it is
uncertain whether early detection and treatment of PCa
leads to a reduction in disease-related mortality [3,4].
Preliminary results from two large randomized con-
trolled cancer screening trials (RCTs) have recently been
published [5,6]. While one trial found a 20% reduction
in death from PCa as a result of screening [6], findings
from the other trial showed no significant reduction in
disease-related mortality [5]. Given these inconclusive
results, the uncertainties regarding screening continue.
The final mortality results from these trials will not be
available for several years.
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the availability of definitive outcome data has been a
long-standing issue in cancer screening [7-9] that is
likely to become increasingly important as advances in
screening technology outpace our ability to validate
effectiveness [10-14]. Currently, there is no national
standard of care with regard to PCa screening and
national medical organizations differ in their screening
recommendations [15-21]. However, most recommend
that men learn about the pros and cons of PCa screen-
ing in order to reach an informed decision [16-19,21].
Thus, widely applicable and easily disseminable
approaches to health education are needed [22].
Informed decision making occurs when individuals
understand the benefits, risks, alternatives and uncer-
tainties surrounding a medical condition or procedure
and are able to use this information in conjunction with
their preferences to make a decision that is consistent
with those preferences [23]. One approach to promoting
informed decisions for PCa screening is the use of
patient education materials and decision aids (DAs).
The goals of DAs are to foster informed health decisions
by: 1) providing facts about the condition and proce-
dures; 2) helping patients to clarify personal preferences
and values; and 3) encouraging discussions with medical
professionals to guide health decisions that match these
preferences [24]. DAs are considered particularly useful
when efficacy is unclear, outcomes are uncertain, and/or
subjective judgments about benefits and risks are
required [24]. Cancer screening-related DAs are particu-
larly important because they have been found to
increase cancer-related knowledge without increasing
anxiety [25].
Increasingly, cancer screening decision tools have
begun to utilize the Internet [26-31]. Despite the digital
divide and differences in Internet use among different
age and racial groups [32], the percentage of Americans
who use the Internet is continuing to grow [33,34].
Internet users who access medical or health information
have also increased between 2001 and 2007, from 66%
to 76% for those aged 50 to 64 and from 60% to 71%
for those over 65 [32]. These trends suggest that the
Internet has vast potential as a widely accessible
approach to delivering decision support materials for
PCa screening.
The most recent systematic review of DAs for PCa
screening was published in 2007, which presented the
findings of 12 RCTs [35]. While we did not conduct our
own systematic review, we used the same Medline
search criteria used in Volk’sr e v i e w( ’prostate cancer’
and ‘decision making’) to locate RCTs published since
the review, between January 2007 and June 2009. We
located an additional six trials [27-29,36-38], and thus
there have been a total of 18 published RCTs evaluating
materials designed to improve informed decision making
regarding PCa screening [26-29,36-49]. These trials have
assessed print, verbal, Internet, video and interactive
computer-based PCa screening DAs. We have provided
as u m m a r yo ft h e s e1 8p u b l i s hed RCTs (see Additional
File 1). Quasi-experimental studies [50-54], abstracts,
and studies evaluating DAs designed to increase PCa
screening were excluded from our summary. Of the 16
trials that assessed knowledge, all reported a significant
improvement. However, inconsistencies were seen
among the trials with respect to changes in decisional
conflict, screening behavior, intent to screen, and active
participation in the screening decision (see Additional
File 1).
Although these were well-conducted trials, there were
several limitations in the development and evaluation of
these DAs. First, only 5 of the 18 studies [27,38,40-42]
included a values clarification component to assist men
in integrating the information and elucidating their pre-
ferences about PCa screening. This may explain why
most studies reported only a modest improvement in
participants’ knowledge, or modest reductions in deci-
sional conflict [27-29,37,40,41,43-46,48]. Second, of the
4 web-based DAs, only one [27] utilized an interactive
format, while the other studies with web-based interven-
tions did not exploit the strengths of this medium
[26,28,29]. Third, while one web-based tool utilized a
tracking mechanism to monitor whether participants
viewed the website [27], that study did not determine
whether the amount of time spent and topics accessed
on the site impacted outcome measures. Fourth, several
of the studies reporting pre- and post-intervention eva-
luations had a brief follow up period of less than 1
month, thereby limiting the understanding of the long-
term impact of the interventions on screening behavior
and other outcomes [28,38,40,41,43,44]. Finally, only 4
of the RCTs included a substantial number of African
American (AA) men, who are at greatest risk for PCa
[36,38,42,45].
Our goal was to extend these prior studies by develop-
ing two new patient DAs, a booklet and an interactive
web-based tool, that could be utilized in a variety of set-
tings. We sought to create widely disseminable and rele-
vant materials that would improve PCa knowledge and
assist a heterogeneous population of men in making
informed screening decisions. We incorporated a values
clarification component into each DA, which is intended
to help individuals determine their personal preferences
and beliefs about PCa screening and to make informed
choices in accordance with those preferences. We are
currently conducting a three arm RCT (including a
usual care arm) to assess the efficacy of these tools
among a diverse sample of men accrued from primary
care clinics. This paper describes the development and
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prior feasibility studies and randomized trials, each of
which contributed to the evolution of these tools.
Methods
Development of Decision Aids
The development of the booklet and website was guided
by two print booklets we had previously created and
evaluated (Studies 1 and 2). Further, we conducted two
feasibility studies and usability testing to confirm the
viability of developing and testing a web-based decision
tool (Study 3). All studies were approved by the George-
town University/Medstar Oncology Institutional Review
Board.
Study 1- The Right Decision is Yours: A Guide to Prostate
Cancer Check-ups
Our initial version of the booklet was developed in col-
laboration with the Most Worshipful Prince Hall Grand
Lodge of the District of Columbia (Masons) and was
targeted to AA men and their spouses [55]. We con-
ducted eight focus groups (N = 44) with AA men
between the ages of 40 and 70 to determine the target
population’s informational needs and to guide the con-
tent and format of the booklet. We conducted two addi-
tional focus groups with internists, family physicians,
and urologists to obtain input about factual information
to include in the booklet.
Thematic analyses of transcripts of the lay focus
groups, along with input from the physicians and guide-
lines of the Centers for Disease Control and Prevention
for the development of educational materials (i.e., clear
presentation, logical sequence, ease in understanding,
and interesting, familiar, realistic, positive images) aided
in the creation of pilot materials [55,56]. We modified
the pilot materials based on iterative feedback from
f o c u sg r o u p s ,m e m b e r so ft h eP r i n c eH a l lM a s o n s ,a n d
the entire project team.
The end product, completed in May 2000, was a 16-
page educational booklet entitled The Right Decision is
Yours: A Guide to Prostate Cancer Check-ups and tar-
geted specifically to AA men [55,57]. We found that the
print intervention increased knowledge and reduced
decisional conflict when compared to videotape and
control conditions, and that screening behavior was not
associated with either of the interventions [45].
Study 2- Prostate Cancer Screening: Making an Informed
Decision
In our next study, we revised the above booklet to target
men of all ethnic and racial backgrounds. The additions
to the content were adapted from a Centers for Disease
Control and Prevention educational tool [58] and pro-
vided information about the leading causes of death
among men, the accuracy of the prostate-specific
antigen (PSA) test, and the treatment decisions that
need to be considered when PCa is diagnosed.
Additionally, we included a 10-item values clarification
component (adapted from Gattellari and Ward, 2003)
[40] to help participants weigh the relative benefits and
risks of screening. The balance sheet consisted of five
items that addressed the benefits of screening (e.g., “I
am worried about PCa and screening may give me
peace of mind”) and five items that addressed the limita-
tions of screening (e.g., “Id on o tw a n tt or i s kf i n d i n g
out I have cancer when it may never bother me”). Parti-
cipants were asked to consider each item and indicate
those ‘that sound like you.’ The purpose of the exercise
was to provide men with a descriptive rather than a pre-
scriptive summary of the screening objectives that were
important to them. Their response patterns suggested
whether they were leaning toward or away from getting
screened.
We conducted 8 usability testing sessions with 3-4 men
per session (total N = 29; 74% AA, 22% White, and 4% of
Caribbean/West Indian descent; age 40-70). The majority
of participants were recruited from fliers posted at Geor-
getown University Hospital (GUH), Howard University
Hospital, the National Prostate Cancer Coalition, and the
local fire department. Participants provided feedback on
the style and method of presentation of the information
to ensure that the booklet addressed relevant topics and
that the uncertainty surrounding screening was
addressed in a balanced manner. Further, participants
gave their opinion of the values clarification component
and suggested ways to improve the balance sheet.
Based on the usability testing findings and research
team recommendations, a plain language specialist was
consulted to ensure that the DA did not exceed an 8
th
grade reading level. The end product, a 24 page booklet
entitled Prostate Cancer Screening: Making an Informed
Decision, was completed in July, 2004. We evaluated the
booklet in a RCT among men who were registered to
undergo free screening [59], comparing this booklet to
the PSA question and answer fact sheet developed by
the National Cancer Institute [60]. Similar to Study 1,
exposure to the DA resulted in a significant increase in
k n o w l e d g ea n dad e c r e a s ei nd e c i s i o n a lc o n f l i c tb u tn o
change in screening behavior.
Study 3- Prostate Cancer Screening: Making the Best Choice
Overview The development of our final set of materials
was conducted in several steps. We conducted two stu-
dies to assess the feasibility of an Internet-based PCa
screening decision tool. Next, we drafted both the new
booklet and the website based on the materials
described in Studies 1 and 2. Finally, we conducted
usability testing to obtain feedback on our draft
materials.
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of our target population’s access to and knowledge of
the Internet. To do this, we conducted two feasibility
studies with men accrued from the primary care clinics
at two Washington, DC teaching hospitals, GUH and
the Washington Hospital Center (WHC), the accrual
sites for the target population in the ongoing RCT.
GUH and WHC serve different populations with regard
to race/ethnicity and socioeconomic backgrounds. GUH
serves a racially diverse and middle to upper-middle
class patient population, while WHC serves a largely AA
patient population of predominately lower- to middle-
class socioeconomic status.
We conducted feasibility studies with patients from
both hospitals to determine how our materials should
be tailored in order to meet the needs of each group.
The feasibility studies were conducted 18 months apart
to examine how Internet access and use changed among
this population of men over time (January 2005 and
June 2006). For each study, men between the ages of 45
and 70 without a previous diagnosis of PCa were
accrued from the waiting rooms of the primary care
clinics at GUH and WHC. Participants completed a
brief survey that contained questions about sociodemo-
graphic information, PCa screening knowledge, and typi-
cal Internet use (see Table 1 for the sample description)
(See Additional file 2). In the second study, we added
the Newest Vital Sign component, a measure of medical
literacy, to the questionnaire (See Additional file 3) [61].
Development of the Booklet and the Website The
study team and consultants first drafted a new version
of the booklet. The primary differences from the prior
booklet included both substantive changes (e.g., addi-
tional information on screening recommendations, dif-
ferent methods of PSA measurement, and additional
figures and statistics) as well as improved readability (e.
g., layout changes, improved wording, adding text boxes
to highlight main points, greater use of bulleted text,
reordering of topics). At each step in the development
process, members of our research team, including pri-
mary care physicians and researchers specializing in PCa
screening education, reviewed and modified drafts of the
booklet.
After finalizing the content of the new booklet, we
began working with the web developers to design the
website prototype. We provided them with both the
draft form of the booklet and a list of website features
to include or avoid, based on our review of several exist-
ing health websites. We sought to create a universally
functional site by accommodating varying web-browsers
(e.g., Internet Explorer, Safari), using Adobe Flash ™ in
the user interface, and using open source development
tools to facilitate flexible site maintenance and support.
The time required to load pages made the website
unsuitable for dial-up connections. However, the results
of the second feasibility study confirmed widespread
access to high-speed Internet, and we anticipated even
greater broadband use after the completion of the ran-
domized trial.
The booklet and website were edited by a plain lan-
guage expert who provided guidance on the presentation
of the information, including the use of parallel sentence
construction, bolded headers and sub-headers to alert
readers to changes in topic, the use of bulleted text and
tabs on the right edge of the pages, and the inclusion of
a detailed glossary that defined medical terms often mis-
understood by laypersons. The presentation of content
on the website was designed to improve its appeal to
persons who may not be regular web-users. We omitted
sections of text to increase readability and wrote the
materials in the conditional tense to prevent the reader
from misinterpreting the information. Importantly, we
acknowledged men’s uncertainty surrounding screening
in an effort to help them consider information that con-
flicted with their prior beliefs. Both the booklet and the
w e b s i t ew e r ew r i t t e na to rb e l o wa n8
th grade reading
level based on the Fleish-Kincaid grade level formula
[62].
The development of these materials was also guided
by criteria from the International Patient Decision Aid
Standards (IPDAS) Collaboration, a worldwide group of
health-care practitioners and researchers who have
developed standards for DAs [63]. IPDAS standards
help researchers create DAs to prepare patients to have
conversations with their physicians about medical tests
and procedures [64].
Booklet Usability testing We recruited participants
(N = 14) from GUH and WHC primary care clinic wait-
ing rooms, from fliers placed in surrounding neighbor-
hoods, and from a General Education Development
center to ensure inclusion of men with limited literacy.
M e nw e r ee l i g i b l ei ft h e yw e r e4 5 - 7 0y e a r so l da n dh a d
not had PCa. Participants reviewed the booklet in our
research offices (N = 6), as well as the clinic waiting
room (N = 7) and their own home (with follow-up to dis-
cuss his feedback; N = 1) in order to accommodate their
schedules.
At the start of each session, one to two members of
the research team held a brief discussion with partici-
pants regarding their prior experiences with screening
to ensure that no one had had unusual experiences that
would impact their feedback. Participants then individu-
ally reviewed the booklet and completed a brief ques-
tionnaire concerning their opinions of the DA, their
overall health, and demographic information (See Addi-
tional file 4). Moderators noted participants’ recommen-
dations for modifications to the text, graphs, figures,
and their impressions of the overall message of the DA.
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tive analyses, as we had previously done in Study 1 [55].
The majority of the content was decided upon from the
previous versions of our materials and through updates
gained from the CDC [58]. We conducted the usability
testing to assess men’s reactions to the presentation of
the materials. The usability testing concluded with a
brief questionnaire that inquired about men’so p i n i o n s
of the materials and demographic information.
Website Usability testing Participants for the usability
testing were again recruited from GUH and WHC pri-
mary care clinics. Usability testing of the website
involved the same recruitment method and protocol
described above for the booklet usability testing. How-
ever, all but one session was conducted in our research
offices. Following the consent process, we provided an
explanation of the rationale for the website and then
asked participants to individually review the proposed
Table 1 Feasibility Study 1, January 2005
GUH (N = 34) WHC (N = 21) Total (N = 55)
Age (N = 55) M = 55.4
SD = 8.2
M = 53.7
SD = 6.7
M = 54.7
SD = 7.6
Race/Ethnicity #
White (N = 19) 50% 10.5% 35.8%
African American (N = 30) 38.2% 89.5% 56.6%
Other (N = 4) 11.8% 0 7.5%
Education
< HS grad (N = 14) 20.6% 33.3% 25.5%
Voc/trade or some college (N = 12) 14.7% 33.3% 21.8%
College Graduate (N = 7) 20.6% 0 12.7%
Graduate work/degree (N = 22) 44.1% 33.3% 40.0%
Marital Status
Married (N = 37) 70.6% 61.9% 67.3%
Other (N = 18) 29.4% 38.1% 32.7%
Internet access at home/work
Yes (N = 41) 82.4% 61.9% 74.5%
No (N = 14) 17.6% 38.1% 25.5%
Home/Work Computer Internet Usage (among those with access at home/work)
Few times yr/few times month (N = 7) 7.1% 38.5% 17.1%
Once/twice a wk (N = 5) 14.3% 7.7% 12.2%
Daily (N = 29) 78.6% 53.8% 70.7%
Receiving Health Related Information #
Prefers Internet (N = 23) 47.1% 36.8% 43.4%
Prefers Booklet (N = 30) 52.9% 63.2% 56.6%
Willingness to Read Prostate Cancer Info on the Internet #
Definitely/Probably would (N = 42) 76.5% 84.2% 79.3%
Definitely/Probably would not (N = 11) 23.5% 15.8% 20.7%
Awareness of Disagreement in Medical Community Regarding Whether to Screen for PrCa
Unaware of disagreement (N = 45) 82.4% 81.0% 81.8%
Aware of disagreement (N = 4) 2.9% 14.3% 7.3%
Not Sure (N = 6) 14.7% 4.8% 10.9%
# N = 2 subjects with missing data
GUH = Georgetown University Hospital, WHC = Washington Hospital Center
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site usability testing sessions were not recorded. How-
ever, one to three members of the research team
observed each participant during the review process to
look for navigation and usability issues and take note of
verbal comments made by participants. The meetings
ended with an informal discussion and a questionnaire
to assess participants’ thoughts, likes, and dislikes of the
materials (See Additional file 5).
Results
Feasibility Studies
Sample
For the initial feasibility study (January 2005), 55/58
(95%) men agreed to participate. The mean age of parti-
cipants was 54.7 (SD = 7.6), with a little over half of the
men reporting that they were AA (Table 1).
The second feasibility study (June 2006) had a partici-
pation rate of 83% (99/119). The sociodemographic
characteristics of these participants were virtually identi-
cal to that of the first feasibility study (see Table 2),
with a mean age of participants of 54.6 (SD = 7.4) and
just over half AA.
Results
Responses to the first feasibility study indicated that,
regarding PCa screening knowledge, 97.1% of men at
GUH and 85.7% at WHC endorsed the belief that
‘experts agree that all men should be tested for PCa.’
This suggested a lack of understanding of the uncertain-
ties surrounding screening. Overall, the majority of men
with Internet access at home or work reported accessing
the Internet a few times a week or daily (82.9%).
Further, 79.3% of all men indicated they would ‘prob-
ably’ or ‘definitely’ read information about PCa on the
Internet. We did not compare the two sites for statisti-
cally significant differences as the goal was simply to
describe the men present at each site.
In the second feasibility study, a majority of men
reported having Internet access at home or work
(70.7%), and just over half reported preferring to receive
health related information on the Internet (53.8%). The
mean total score for the Newest Vital Sign scale was 3.9
(SD = 2.0) at GUH and 1.9 (SD = 1.8) at WHC. Scores
on the Newest Vital Sign scale range from 0 to 6, with
fewer than four correct answers indicating the possibility
of limited literacy.
The feasibility studies identified the need for educa-
tional tools to improve men’s knowledge of the uncer-
tainties surrounding PCa screening. Responses to the
Internet access and use questions confirmed that the
Internet was a feasible medium for a widely accessible
PCa screening educational tool. Although these were
not representative samples, the data suggest that a
majority of men had access to the Internet, and this
access was sustained over time. These results further
supported and gave us confidence in our decision to
create a website that used a broadband Internet connec-
tion (as opposed to a dial-up connection) in order to
deliver more complex interactive and video features.
Participants’ scores on the Newest Vital Sign reinforced
the need for a plain language specialist in developing
text for the website and the booklet.
Booklet Usability testing
Sample
The mean age of participants (N = 14) was 53.8 (SD = 7.8).
Half of the men were unemployed or retired and 71.4%
were AA. Additional demographic information for these
participants is presented in Table 3. Given the overlap
between the groups of men who reviewed the booklet and
the website (N = 6 reviewed both), we did not assess the
potential differences between the two groups.
Results
Responses to the questionnaire are presented in Table 3.
Half of the men reviewing the booklet indicated that it
h a da b o u tt h er i g h ta m o u n to fi n f o r m a t i o na n dw a s
about the right length, but a substantial minority
reported that it contained more information than they
would have liked (42.8%) or was too long (35.7%).
Despite our efforts to provide balanced information, a
majority of men (71.5%) said that the overall message of
the booklet was that they should probably or definitely
get screened for PCa. Many participants indicated that
they were unaware of the uncertainty surrounding PCa
screening. This suggested that a single discussion of the
uncertainty was not enough to impact men’su n d e r -
standings of this complex topic.
In general, men were positive about the booklet, but
many provided suggestions for information they would
like to have added (Table 4); the content and layout of
the booklet were revised accordingly. For example, the
values clarification component presented in the Study 2
booklet, containing a non-prescriptive balance sheet,
was simplified based on feedback from usability testing
participants (see Figure 1). Participants were asked to
select which of 10 statements ‘sound like you,’ with five
highlighting the benefits of screening and five highlight-
ing limitations. Participants’ responses were intended to
indicate whether they leaned toward or away from
screening. Because many men found the original ques-
tions to be complex, we tested multiple versions of the
questions.
Table 5 summarizes the booklet content and discusses
the similarities and differences between the booklet and
the web-based DA. We maintained consistency between
the content of the booklet and website but note differ-
ences related to the interactive features of the web-
based tool.
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Sample
Overall, 14 men reviewed the website, six of whom had
previously reviewed the booklet. The mean age of parti-
cipants was 54.0 (SD = 7.2). Despite the small sample
s i z e ,h a l fo ft h ep a r t i c i p a n t sw e r eA Aa n dh a l fw e r e
employed. Additional demographic information for
these participants is presented in Table 3.
Results
Based on the questionnaire data, one-half (50%) of the
men said the site provided about the right amount of
information and 42.9% said it was about the right
Table 2 Feasibility Study 2, June 2006
GUH (N = 50) WHC (N = 49) Total (N = 99)
Age (N = 98) # M = 53.9
SD = 7.5
M = 55.2
SD = 7.3
M = 54.6
SD = 7.4
Race/Ethnicity †
White (N = 35) 52.0% 20.0% 36.8%
African American (N = 48) 28.0% 75.6% 50.5%
Other (N = 12) 20.0% 4.4% 12.6%
Education
< HS grad (N = 25) 10.0% 40.8% 25.3%
Voc/trade/some college (N = 19) 10.0% 28.6% 19.2%
College Graduate (N = 18) 26.0% 10.2% 18.2%
Graduate work/degree (N = 37) 54.0% 20.4% 37.4%
Marital Status *
Married (N = 53) 78.0% 29.8% 54.6%
Other (N = 44) 22.0% 70.2% 45.4%
Internet access at home/work
Yes (N = 70) 92.0% 49.0% 70.7%
No (N = 29) 8.0% 51.0% 29.3%
Home/Work Computer Internet Usage (among those with access at home/work)
Never/Rarely (N = 1) 0.0% 4.2% 1.4%
Few times per year/few per month (N = 4) 2.2% 12.5% 5.7%
Once a week/several times a week (N = 14) 17.4 25.0% 20.0%
Daily (N = 51) 80.4% 58.3% 72.9%
Receiving Health Related Information ￿
Prefers Internet (N = 45) 66.0% 30.4% 48.4%
Prefers Booklet (N = 43) 25.5% 67.4% 46.2%
No preference (N = 5) 8.5% 2.2% 5.4%
Willingness to go to another location if no access to high-speed Internet connection? *‡
Yes (N = 16) 33.3% 45.2% 43.2%
No/Not sure (N = 21) 66.7% 54.8% 56.8%
Newest Vital Sign (NVS)
^ (N = 99) M = 3.9 SD = 2.0 M = 1.9 SD = 1.8 M = 2.9 SD = 2.2
#N = 1 subject with missing data
† N = 4 subjects with missing data
* N = 2 subjects with missing data
￿ N = 6 subjects with missing data
‡ Includes participants with slow-speed Internet access and no Internet access
^ Scores on the NVS range from 0 to 6, with fewer than four correct answers indicating the possibility of limited literacy
GUH = Georgetown University Hospital, WHC = Washington Hospital Center
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tation of the issues, only 35.7% indicated that the web-
site’s overall message neither favored nor opposed PCa
screening. Although far short of our goals, this was an
improvement over our prior decision tools and over the
current booklet (see Table 3). Anecdotal information
suggested that this viewpoint may be most prevalent
among men who were screened regularly, as they may
have taken note of the benefits of screening more so
than the limitations. Table 4 describes revisions made to
the website based on usability testing feedback. Changes
related to content were made to both the website and
booklet.
A primary concern during website development was
w h e t h e rm e nw i t hl i t t l eo rn oc o m p u t e re x p e r i e n c e
could successfully use the site. Based on difficulties
experienced by three participants with little to no com-
puter experience, several necessary modifications were
made to the site to make it more user-friendly (Table
4). Difficulties in site navigation would have been over-
looked if only computer savvy men had been sampled.
While some men initially had trouble using the website,
they were all ultimately able to successfully navigate the
site and understand its content after viewing printed
instructions.
Based on usability testing and recommendations from
the research team, the web developers created several
iterations of the website before a release candidate was
created, approved, and launched. The website required
30-50 minutes to review and had a literacy level that did
not exceed an eighth grade reading level. Importantly,
the website aimed to present information in a balanced
manner, neither encouraging nor discouraging screen-
ing. The web developers continue to provide ongoing
technical support to ensure that team members and
study participants do not encounter difficulties using the
website.
Table 5 also provides details on the nine topic areas
presented in the website as well as the booklet, includ-
ing content features, similarities and differences with
regard to the presentation of information, as well as a
description of how general features differ between the
two formats (e.g., audio vs. text, graphics). The final ver-
sions of the booklet and website, entitled Prostate Can-
cer Screening: Making the Best Choice, were completed
in October 2007. The remainder of the Results section
is devoted to the description of specific interactive fea-
tures of the website.
Components of the Website
The interactive features of the website enabled an
expansion and customization of the material. For exam-
ple, web-users could access additional external informa-
tion (e.g., the resource page included links to the
homepages of national organizations that provide more
information on PCa screening and treatments) or could
use the table of contents to easily navigate to other sec-
tions of interest.
The website was made more accessible to men with
limited literacy by presenting the majority of the text via
voice over. Audio was available for approximately 70%
Table 3 Evaluation Data from Usability testing (Study 3)†
Booklet Web
N=1 4 N=1 4
Age M = 53.8 M = 54.0
SD = 7.8 SD = 7.2
Race
White 28.6% 50.0%
African American 71.4% 50.0%
Education
<HS grad 21.4% 35.7%
Some college 42.9% 21.4%
College Graduate 14.3% 0.0%
Graduate work/degree 21.4% 42.9%
Marital Status
Married/living as married 50.0% 35.7%
Not married 50.0% 64.2%
Employment Status
Not employed/Retired 50.0% 50.0%
Employed 41.9% 50.0%
Health Insurance
Yes 92.9% 78.6%
How often Screened
3-6 months 7.1% 14.3%
Annually 50.0% 42.9%
Every 2 years 0.0% 0.0%
Don’t know/Missing 42.9% 42.9%
Prior Abnormal Screening Result
Yes 7.1% 7.1%
Amount of Information Provided
Much/A little less info than wanted 7.1% 21.4%
About Right 50.0% 50.0%
A little more/a lot more info than wanted 42.8% 21.4%
Length of booklet/website
Much too long/a little too long 35.7% 50.0%
About right 50.0% 42.9%
Wanted a little/much longer 14.2% 7.1%
Clarity
Everything/most things clear 85.7% 92.9%
Some Clear 7.1% 7.1%
Many unclear 0.0% 0.0%
Missing data 7.2%
Overall Message
Definitely/Probably not screen 14.3% 14.3%
Neither 14.3% 35.7%
Definitely/Probably Screen 71.5% 42.8%
† No significance testing was conducted due to overlap between groups
(6 men participating in web usability testing also participated in booklet
usability testing)
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Page 8 of 17Table 4 Feedback and Subsequent Changes from Usability testing (Study 3)
Concern Solution
Booklet Usability testing
Questions about age- and race- adjusted PSA - Sections added with this material
Complex material - Plain language consultant was used
- Changed in text based on comments from men
- Used bullet points and short sentences
Complex DA questions - Multiple versions of the DA questions were created and tested
Website Usability testing
Little experience using the Internet - Instructions and a troubleshooting packet provided to user
- Instructions provided on the website
Complex material - Used less text on each screen
- Increased use of bullet points
- Audio summarized what is on the page for the participant
- New “vocabulary” words have a hyperlink to a pop-up with their definition
Figure of prostate looks “cartoon-like” - Changed figure and other graphics to look more realistic
Some men commented that they would like to see
audio on the pop-ups.
- Web developers and researchers decided that this would be too distracting;
this suggestion was not implemented.
- Audio was put on all main pages for consistency.
Figure 1 Booklet Values Clarification Component (Adapted from Gattellari & Ward (2003)[40].
Dorfman et al. BMC Medical Informatics and Decision Making 2010, 10:12
http://www.biomedcentral.com/1472-6947/10/12
Page 9 of 17Table 5 Comparison of the Booklet and Web-based Educational Tools (Study 3)
Section Summary of Content Features/Differences between Booklet and Web
Title page & introduction - Why you should read the material - The website included a tutorial on how to use the
program and its interactive features, such as video
testimonials, pop-outs, and animated diagrams.
- Includes table of contents - The website required participants to answer a
question regarding their current beliefs about
screening before they began reviewing the website.
This question was followed by 2 tailored video
testimonials.
- The booklet table of contents was located on the
second page, and the booklet included section tabs
along the edges of the pages for easy access to
specific topics.
- The website table of contents was presented along
the left side of each screen and allowed participants to
select where to begin.
Know the basics about the
prostate gland
- What is the prostate, types of prostate problems - The first values clarification question was presented
on the website.
Understand why there is no right
or wrong choice about prostate
cancer screening
- Definition of screening, description of screening
tests, screening recommendations from national
organizations
- Two values clarification questions were presented on
the website.
- Information about whether screening will help men - Two video testimonials were presented on the
website.
Learn the facts about prostate
cancer screening
- Steps involved in screening - Four values clarification questions were presented on
the website.
- Screening accuracy - The website provided pop-out boxes with additional
information about PSA testing (i.e. PSA velocity, race-
and age- adjusted PSA, free vs. attached PSA).
- Is screening right for you - The booklet had a tree branch diagram describing
screening accuracy, while the website had an
animated diagram with text and audio.
- The booklet provided testimonial quotes from men
who believed that screening was helpful and who
questioned whether getting screened was helpful.
Facts you should know if prostate
cancer is found—treatment issues
- Deciding whether to treat prostate cancer: the risks
of engaging in watchful waiting and the risks of
treating the cancer.
- Three values clarification questions were presented
on the website.
- Information about Gleason Score, PIN, and over
treatment
- Two video testimonials were presented on the
website.
- Treatment decisions and factors to consider - The website included pop-outs discussing the side
effects of active treatment for prostate cancer.
- Types of active Treatment
- Information about late stage prostate cancer
- Side effects of treatment
Steps you can take to make the
best choice about whether to be
screened for prostate cancer
- Know your risk factors: age, history, race, diet - The website provided pop-outs with statistics about
risk factors, symptoms, etc. (provided charts and
graphs).
- Learn the symptoms - The booklet provided a space where men could
write in questions they would like to ask their doctor
about prostate cancer screening.
- Talk with your doctor about screening—includes
questions to consider when discussing screening with
your doctor
- The website allowed for men to print out the
questions to ask their doctor that have been provided
and urged men to write down any additional
questions they had.
Values Clarification Exercise - Instructions for how to complete the worksheet - The booklet presented the worksheet questions on
two pages, separating statements from men who
decided to get screened from men who have decided
not to get screened.
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Page 10 of 17of the text, and 80% of the audio matched the text ver-
batim. Users could deactivate the audio if they preferred
to only read text.
The website included eight testimonials, prepresented
as video clips of men speaking about their screening
decision, whereas the booklet included written quota-
tions from two men (one pro, one con). The videos
enabled users to view the emotional reactions and facial
expressions of the different actors as they relayed perso-
nal stories about PCa screening. We utilized actors that
represented a racially diverse group of men in an effort
to help make the information more relevant and under-
standable [31]. Of the eight video testimonials pre-
sented, 3 of the actors were AA, two were white, one
was Asian, one was Native American, and one was
Hispanic.
T h ei n t e r a c t i v en a t u r eo ft h ew e b s i t ei n s u r e dt h a t
users were exposed to a perspective about PCa screen-
ing that differed from their own, in an effort to address
the presence of a confirmation bias [65]. To do this,
users indicated their history of screening, which was
assessed upon entry into the website. The first two
video testimonials were tailored so that a user who was
leaning toward screening first viewed two testimonials
of men who chose not to get screened, and vice versa
for men leaning against screening. In subsequent sec-
tions of the website, the remaining six testimonials (3
pro, 3 con) were presented back to back so that
everyone viewed all 3 pairs. The race of the actors var-
ied so that the pro and con messages were delivered by
actors of different races.
The 10-item values clarification component described
above for the booklet was also included on the website
in an interactive format (Figure 2). Individual items
were presented at the end of different content sections
a n du s e r sw e r ep r o m p t e dt or e s p o n d :‘sounds like me,’
‘does not sound like me ‘or ‘not sure yet.’ Questions
that men skipped as they navigated through the site
were automatically entered as ‘not sure yet.’ The ques-
tions were displayed again at the end of the website to
provide men with an opportunity to change the
response. Responses to all items were then depicted on
a balance scale to help men determine if they leaned
toward or away from getting screened. Finally, users
always received a prompt to review the values clarifica-
tion tool upon exiting the website; thus, it was seen by
all men, even those who did not review the entire
website.
The web-based format also allowed for animation and
graphics to draw attention to key points and direct the
user through the website. For example, a graphic of 100
men that illustrated the accuracy of the PSA test chan-
ged colors to distinguish subgroups from the whole and
was accompanied by a voiceover that explained the fig-
ure (Figure 3). The booklet, however, provided a single
tree diagram to depict the same statistics (Figure 4).
Table 5: Comparison of the Booklet and Web-based Educational Tools (Study 3) (Continued)
- The worksheet—includes 10 questions to determine
if men are leaning towards or away from screening
- The website allowed men to review and change their
answers to questions, and to view a results page with
a balance beam diagram. The balance diagram
showed participants if they leaned toward screening or
against screening. Men could print a summary of their
responses.
- Values clarification questions were asked throughout
the site and were located in sections corresponding to
the content of the question.
Learn more about prostate cancer - Charts and graphs about ways to measure PSA,
disease incidence and mortality, concerns about
active treatment for older men, and side effects from
treatment
- The information that was seen in pop-ups earlier in
the website was also available again at this point in
the website, but the information was available in the
booklet for the first time.
Additional sources for information
about screening
- Glossary - The website provided hyperlinks to the websites of
organizations that could provide men with further
information about prostate cancer.
- References
- Contact information for organizations
General features - Audio vs. text - Only the website allowed for audio.
- Pop outs vs. text boxes - The website featured pop-out boxes, while the
booklet had text boxes highlighting important
information.
- Graphics - There were more visual features and graphics on the
website than on the booklet, due to the nature of the
website’s design.
- Testimonials - The website presented 8 video testimonials, while the
booklet presented 2 testimonial quotations.
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the materials and provides data on the behaviors of visi-
tors. Data stored in a password protected Structured
Query Language database provides records of the time
spent visiting the website, time spent in each section,
and responses to the DA queries. Upon completion of
the RCT, this information will help determine whether
initial screening preferences and usage patterns are asso-
ciated with knowledge acquisition, decisional conflict,
baseline screening preference, and subsequent screening
decisions.
Discussion
There is considerable interest in assisting men with PCa
screening decisions, as evidenced by the 18 RCTs con-
ducted to assess the efficacy of DAs. We sought to
address several limitations of the previous studies with
the development of two disseminable tools with
Figure 2 Website Values Clarification Component (Adapted from Gattellari & Ward (2003))[40].
Figure 3 Website Screenshot of Animation Depicting the Accuracy of the PSA Test [83-85].
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interactive website. The booklet and the website offer
the identical content, while the website also includes an
interactive values clarification component, video testi-
monials, and tracking software to assess men’su t i l i z a -
tion of the website. The website recently received the
2009 American Public Health Association’sa w a r df o r
Public Health Education Materials [66]. Our ongoing
RCT will examine the impact of the website and booklet
on PCa screening knowledge, decisional conflict, satis-
faction with decision, health-related quality of life and
screening behaviors. The trial will be completed in 2011.
Our new materials offer several improvements over
prior DAs. Given the persistent problem created by the
digital divide, regarding both limited access and prefer-
entially attracting Internet-savvy users, we designed fea-
tures of the website to appeal to more diverse groups.
Our formative work and prior randomized trials
Figure 4 Booklet Depiction of the Accuracy of the PSA Test [83-85].
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participants from diverse socioeconomic backgrounds,
which provided insights to design materials for these
groups. For example, our DAs maintained a maximum
of an 8
th grade reading level, information was provided
in plain language, and a glossary defined terms used
throughout the website and booklet. Further, we incor-
porated visuals, graphs and charts, all of which have
been suggested as methods for increasing comprehen-
sion among low-literacy groups [31].
In addition to making the materials appealing and
understandable to diverse groups of men, we also
assessed the extent of web access within our target sam-
ple. We found that over an 18-month period, web usage
among lower socioeconomic men had increased. These
results are consonant with some findings from the Pew
Foundation [67], although other studies have reported
slower growth among low SES and minority groups
[68]. Our ongoing trial will provide more definitive evi-
dence regarding the impact of web- vs. print-based
media for PCa screening education, as well as the extent
to which we managed to bridge the digital divide. The
testing of these DAs among minorities and low literacy
participants will provide an important opportunity to
validate effectiveness in this population, which tends to
be less informed about screening options and less
engaged in decision-making [69,70].
T oo u rk n o w l e d g e ,o u r si st h es e c o n ds t u d yt o
describe an interactive web-based tool designed to edu-
cate men about PCa screening [27], and the first to uti-
lize tracking software to compare website utilization
patterns with patient outcomes. Potential advantages of
using web-based materials include the relatively low cost
of updating information and the increased capability of
tailoring and interactivity, which may assist in the acqui-
sition and integration of knowledge. For example, by tai-
loring the presentation of the first two video
testimonials in response to the user’s baseline screening
preference, we have insured that men consider counter-
arguments to help balance their perspective. Also, the
interactive nature of the web-based values clarification
exercise was designed to actively engage participants
and enhance the integration of knowledge. This was
intended to help men make a decision that corresponds
more closely with their own values and screening prefer-
ences, decrease decisional conflict, and increase decisio-
nal satisfaction.
Over the course of the development of these DAs, we
have encountered several important issues that may be
useful to others who are creating similar tools. First,
there was a tradeoff between providing detailed informa-
tion vs. risking that the materials would require more
time than men would be willing to devote to them.
Despite our best efforts to be concise, between 35%
(booklet) and 50% (website) of the usability testing parti-
cipants thought the materials were too long. As we did
not want to exclude any pertinent information, it is pos-
sible that the length of our materials may deter some
men from reading all of the text. However, with both
the booklet and the website, we expect that men will
selectively access sections of interest by using the Table
of Contents.
Secondly, when we conducted our web usability test-
ing, we provided a step-by-step instruction sheet for
using the website. Men reported that the instructions
were very helpful, particularly for those with less com-
puter experience. Due to these findings, as well as what
we know about the disparities between SES groups and
Internet use, we have included the instruction sheet in
the current randomized trial to ensure that men with
less experience using the Internet will be able to suc-
cessfully access and use our materials.
Finally, it was challenging to develop a DA that
addressed the uncertainty of a screening test for men
who had been undergoing regular screening and who
were completely unaware of the uncertainty. The balan-
cing act was to validate what men already knew while
also providing information that was both counterintui-
tive and contrary to their previous impression. We
worked to present the materials in an evenhanded fash-
ion; however, results from the usability testing suggested
that only a minority of men thought the booklet (14%)
and website (36%) neither endorsed nor opposed screen-
ing. These findings highlight the fact that it may take
more than a single exposure to materials such as ours
for patients to grasp a message that is both complex
and counter to one’s current understanding and prac-
tices. While our usability testing provided critical infor-
mation during the development process and our sample
size was comparable to other studies involving usability
testing [71,72], a larger sample may have provided the
feedback necessary to more effectively present the
uncertainty and the message of neither endorsing nor
opposing screening.
Conclusion
Despite the uncertainty surrounding PCa screening,
most primary care physicians routinely order the PSA
test for men over 50, and some engage in unsupported
practices, such as screening patients over age 75 and
referring such men for biopsies when PSA values are
elevated [73-75]. Due to the logistic constraints they
face [76], many physicians administer PCa screening
with little opportunity to discuss the test beforehand
[77]. However, evidence indicates that many men would
prefer to make a shared PCa screening decision in con-
junction with their physicians [78-81]. Consequently,
access to an effective DA in the primary care setting
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men in the decisive period before testing occurs. In
2005, 80% of males had at least one visit with an ambu-
latory care physician [82], suggesting that an interven-
tion implemented in this setting could have a
widespread impact.
Providing assistance for informed decision making for
PCa screening may be important for some time, particu-
larly if a definitive recommendation either for or against
screening does not emerge from the ongoing screening
trials. We have detailed our efforts at developing print-
and interactive web-based DAs to assist men in deter-
mining whether they prefer to be screened or not.
Given that technological advances in medical screening
tests will continue to occur faster than clinical transla-
tional research can keep pace, we hope that insights
from the development of our decision tools will be
applicable as other screening dilemmas arise.
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